NMR Second Site Screening for Structure Determination of Ligands Bound in the Hydrophobic Pocket of HIV-1 gp41

被引:31
作者
Balogh, Edina [1 ]
Wu, Dong [1 ]
Zhou, Guangyan [1 ]
Gochin, Miriam [1 ,2 ]
机构
[1] Touro Univ Calif, Dept Basic Sci, Vallejo, CA 94592 USA
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
关键词
FUSION INHIBITOR; MEMBRANE-FUSION; ENFUVIRTIDE; PEPTIDES; MOLECULE; TARGET; SHIFTS; VIRUS; ENTRY; CORE;
D O I
10.1021/ja8094558
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The development of nonpeptide fusion inhibitors through rational drug design has been hampered by the limited accessibility of the gp41 coiled coil target, which is highly hydrophobic, and the absence of structural data defining details of small molecule interactions. Here we describe a new approach for obtaining structural information on small molecules bound in the hydrophobic pocket of gp41, using a paramagnetic probe peptide which binds adjacent to the pocket along an extended coiled coil. Ligand binding in the pocket leads to paramagnetic relaxation effects or pseudocontact shifts of ligand protons. These effects are distance and/or orientation dependent, permitting determination of ligand pose in the pocket. The method is demonstrated with a fast-exchanging ligand. Multiple measurements at different coiled coil and probe peptide ratios enabled accurate determination of the NMR parameters. Use of a labeled probe peptide stabilizes an otherwise aggregation-prone coiled coil and also enables modulation of the paramagnetic effect to study ligands of various affinities. Ultimately, this technique can provide essential information for structure-based design of nonpeptide fusion inhibitors.
引用
收藏
页码:2821 / +
页数:5
相关论文
共 21 条
[1]  
BERTINI I, 1986, NMR PARAMAGNETIC MOL, V3
[2]   A novel fluorescence intensity screening assay identifies new low-molecular-weight inhibitors of the gp41 coiled-coil domain of human immunodeficiency virus type 1 [J].
Cai, Lifeng ;
Gochin, Miriam .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (07) :2388-2395
[3]   Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus [J].
Dwyer, John J. ;
Wilson, Karen L. ;
Davison, Donna K. ;
Freel, Stephanie A. ;
Seedorff, Jennifer E. ;
Wring, Stephen A. ;
Tvermoes, Nicolai A. ;
Matthews, Thomas J. ;
Greenberg, Michael L. ;
Delmedico, Mary K. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (31) :12772-12777
[4]   Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket [J].
Eckert, DM ;
Malashkevich, VN ;
Hong, LH ;
Carr, PA ;
Kim, PS .
CELL, 1999, 99 (01) :103-115
[5]   Mechanisms of viral membrane fusion and its inhibition [J].
Eckert, DM ;
Kim, PS .
ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 :777-810
[6]   Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion [J].
Frey, Gary ;
Rits-Volloch, Sophia ;
Zhang, X. -Q. ;
Schooley, Robert T. ;
Chen, Bing ;
Harrison, Stephen C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (38) :13938-13943
[7]   Resistance to enfuvirtide, the first HIV fusion inhibitor [J].
Greenberg, ML ;
Cammack, N .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (02) :333-340
[8]   Novel techniques for weak alignment of proteins in solution using chemical tags coordinating lanthanide ions [J].
Ikegami, T ;
Verdier, L ;
Sakhaii, P ;
Grimme, S ;
Pescatore, B ;
Saxena, K ;
Fiebig, KM ;
Griesinger, C .
JOURNAL OF BIOMOLECULAR NMR, 2004, 29 (03) :339-349
[9]   Ensemble approach for NMR structure refinement against 1H paramagnetic relaxation enhancement data arising from a flexible paramagnetic group attached to a macromolecule [J].
Iwahara, J ;
Schwieters, CD ;
Clore, GM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (18) :5879-5896
[10]   Second-site NMR screening with a spin-labeled first ligand [J].
Jahnke, W ;
Perez, LB ;
Paris, CG ;
Strauss, A ;
Fendrich, G ;
Nalin, CM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (30) :7394-7395